A detailed history of Gradient Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gradient Capital Advisors, LLC holds 6,391 shares of JNJ stock, worth $990,860. This represents 0.35% of its overall portfolio holdings.

Number of Shares
6,391
Previous 6,349 0.66%
Holding current value
$990,860
Previous $927,000 11.65%
% of portfolio
0.35%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$145.48 - $167.38 $6,110 - $7,029
42 Added 0.66%
6,391 $1.04 Million
Q2 2024

Jul 19, 2024

SELL
$144.38 - $157.78 $156,796 - $171,349
-1,086 Reduced 14.61%
6,349 $927,000
Q1 2024

Apr 17, 2024

SELL
$155.22 - $162.74 $83,197 - $87,228
-536 Reduced 6.72%
7,435 $1.18 Million
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $114,732 - $125,197
-788 Reduced 9.0%
7,971 $1.25 Million
Q3 2023

Oct 24, 2023

BUY
$155.75 - $174.48 $4,205 - $4,710
27 Added 0.31%
8,759 $1.36 Million
Q2 2023

Jul 18, 2023

BUY
$154.35 - $166.11 $71,001 - $76,410
460 Added 5.56%
8,732 $1.45 Million
Q1 2023

Apr 17, 2023

SELL
$151.05 - $180.26 $59,513 - $71,022
-394 Reduced 4.55%
8,272 $1.28 Million
Q4 2022

Feb 03, 2023

BUY
$160.2 - $179.79 $87,309 - $97,985
545 Added 6.71%
8,666 $1.53 Million
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $12,745 - $14,182
79 Added 0.98%
8,121 $1.33 Million
Q2 2022

Jul 18, 2022

BUY
$168.19 - $186.01 $34,142 - $37,760
203 Added 2.59%
8,042 $1.43 Million
Q1 2022

Apr 29, 2022

BUY
$158.14 - $179.59 $1,581 - $1,795
10 Added 0.13%
7,839 $1.39 Million
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $54,419 - $60,380
349 Added 4.67%
7,829 $1.34 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $66,861 - $74,300
414 Added 5.86%
7,480 $1.21 Million
Q2 2021

Aug 02, 2021

BUY
$159.48 - $171.07 $92,817 - $99,562
582 Added 8.98%
7,066 $1.16 Million
Q1 2021

Apr 21, 2021

SELL
$153.07 - $170.48 $126,588 - $140,986
-827 Reduced 11.31%
6,484 $1.07 Million
Q4 2020

Jan 20, 2021

BUY
$137.11 - $157.38 $216,633 - $248,660
1,580 Added 27.57%
7,311 $1.15 Million
Q3 2020

Oct 21, 2020

BUY
$140.38 - $153.83 $27,935 - $30,612
199 Added 3.6%
5,731 $853,000
Q2 2020

Jul 28, 2020

SELL
$128.81 - $155.51 $40,575 - $48,985
-315 Reduced 5.39%
5,532 $778,000
Q1 2020

Apr 22, 2020

BUY
$111.14 - $153.99 $6,334 - $8,777
57 Added 0.98%
5,847 $767,000
Q4 2019

Jan 16, 2020

SELL
$127.5 - $146.44 $61,710 - $70,876
-484 Reduced 7.71%
5,790 $845,000
Q3 2019

Oct 22, 2019

SELL
$126.95 - $142.14 $109,430 - $122,524
-862 Reduced 12.08%
6,274 $812,000
Q2 2019

Jul 16, 2019

SELL
$131.15 - $144.24 $21,508 - $23,655
-164 Reduced 2.25%
7,136 $994,000
Q1 2019

Apr 16, 2019

BUY
$125.72 - $139.79 $377 - $419
3 Added 0.04%
7,300 $1.02 Million
Q4 2018

Jan 30, 2019

BUY
$122.84 - $147.84 $368 - $443
3 Added 0.04%
7,297 $942,000
Q3 2018

Nov 06, 2018

BUY
$121.58 - $142.88 $243 - $285
2 Added 0.03%
7,294 $1.01 Million
Q2 2018

Jul 26, 2018

BUY
$119.4 - $131.76 $36,417 - $40,186
305 Added 4.37%
7,292 $885,000
Q1 2018

Apr 20, 2018

BUY
$125.1 - $148.14 $159,252 - $188,582
1,273 Added 22.28%
6,987 $895,000
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $749,791 - $820,644
5,714
5,714 $798,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gradient Capital Advisors, LLC Portfolio

Follow Gradient Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Capital Advisors, LLC with notifications on news.